Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
specimen carryover | residual material from another sample affects a measurement | The laboratory investigated possible specimen carryover after the unexpected result. | Assessment | Drug concentrations, exposure and assay interpretation |
specimen label verification | matching identifiers, source and collection details on the labeled sample | Request specimen label verification for the two closely timed specimens. | Plan | Sampling, laboratory verification and communication |
specimen verification | confirmation of sample type, site and identity | Request specimen verification from the receiving laboratory. | Plan | Monitoring actions, escalation and result communication |
target not detected | specified assay target was not identified in the submitted sample | The result states "target not detected" for the named target in this specimen. | Objective | Molecular testing, serology and culture findings |
target peak | goal specified for a sample meeting the peak protocol | The value was compared with the target peak only after the sampling window was verified. | Assessment | Drug levels - exposure and pharmacokinetics |
| sample drawn immediately before the next dose under the applicable protocol | The trough was collected at 07:55 before the 08:00 dose. | Objective | Drug levels - collection and dose timing | |
unbound-to-total ratio | free concentration divided by total concentration in comparable samples | The unbound-to-total ratio was interpreted only after checking that both results used compatible units. | Assessment | Medication response, exposure and reconciliation |
absolute monocyte count | actual number of monocytes per unit of blood | The absolute monocyte count remained elevated on a second sample. | Objective | Hematology and transfusion laboratory reporting |
Acholic stools | Clay colored stools | The clinical record describes acholic stools in a stool sample seen in clinic. | Objective | Abdominal, perianal and endoscopic findings |
administration record review | checking the record of doses actually given | Use the administration record review to verify the two doses preceding the sample. | Plan | Medication reconciliation, administration and teaching |
analyte identity check | confirming exactly which chemical, drug or metabolite was measured | Complete the analyte identity check before associating the outside result with the new sample. | Plan | Sampling, laboratory verification and communication |
back-extrapolated peak | peak estimated retrospectively from a later concentration and a model | Record the back-extrapolated peak separately from the measured sample. | Plan | Drug levels - verification and documentation |
Bayesian estimation | model-based estimate combining prior information and patient data | The consult used Bayesian estimation and listed the samples entered. | Plan | Drug levels - verification and documentation |
bronchoalveolar lavage | fluid recovered after instillation into a lung segment for analysis | The bronchoalveolar lavage specimen was labeled with the sampled lobe. | Objective | Pulmonary function, ventilation and oxygen delivery |
busulfan | alkylating agent with protocol-specific pharmacokinetic sampling | Each busulfan sample is linked to the actual infusion record. | Objective | Drug levels - named analytes and exposure reports |
calendar date | date attached to an event or measurement | Record the calendar date for each dose when interpreting overnight samples. | Plan | Monitoring actions, escalation and result communication |
clinical-pathologic correlation | interpretation of tissue findings alongside history and examination | Clinical-pathologic correlation was requested because the sampled site differed from the symptomatic site. | Assessment | Precision in clinical interpretation and documentation |
| maximum concentration in the specified concentration-time profile | The model's Cmax is listed separately from the single timed sample. | Assessment | Drug levels - exposure and pharmacokinetics | |
| measurement of multiple hemoglobin species by spectrophotometry | The sample was analyzed by co-oximetry. | Objective | Electrolytes, acid-base and metabolic testing | |
concentration-time profile | sequence of concentrations linked to actual sampling times | The concentration-time profile was reconstructed using the medication record and sample labels. | Assessment | Drug concentrations, exposure and assay interpretation |
context-dependent finding | observation whose meaning changes with setting, timing or method | The context-dependent finding was interpreted using the actual sample conditions. | Assessment | Precision in clinical interpretation and documentation |
cryoglobulins | proteins that precipitate when cooled under specified test conditions | The reference laboratory detected cryoglobulins in the submitted sample. | Objective | Muscle, joint fluid and inflammatory measurements |
cryptitis | inflammatory cells infiltrate the intestinal crypt epithelium | The pathology report documents cryptitis in the sampled mucosa. | Objective | Tissue pathology and cancer reporting |
cyclosporine | immunosuppressant monitored using a specified timed sampling strategy | The cyclosporine report specifies whether the order was for a predose or two-hour sample. | Objective | Drug levels - named analytes and exposure reports |
dose-normalized trough | trough concentration divided by a defined dose metric | Dose-normalized trough was compared only across samples with confirmed predose timing. | Assessment | Medication response, exposure and reconciliation |